The COVID-19 pandemic,
caused by the severe acute respiratory syndrome
coronavirus-2, SARS-CoV-2, shows the need for effective antiviral
treatments. Here, we present a simulation study of the inhibition
of the SARS-CoV-2 main protease (M
pro
), a cysteine hydrolase
essential for the life cycle of the virus. The free energy landscape
for the mechanism of the inhibition process is explored by QM/MM umbrella
sampling and free energy perturbation simulations at the M06-2X/MM
level of theory for two proposed peptidyl covalent inhibitors that
share the same recognition motif but feature distinct cysteine-targeting
warheads. Regardless of the intrinsic reactivity of the modeled inhibitors,
namely a Michael acceptor and a hydroxymethyl ketone activated carbonyl,
our results confirm that the inhibitory process takes place by means
of a two-step mechanism, in which the formation of an ion pair C145/H41
dyad precedes the protein–inhibitor covalent bond formation.
The nature of this second step is strongly dependent on the functional
groups in the warhead: while the nucleophilic attack of the C145 sulfur
atom on the Cα of the double bond of the Michael acceptor takes
place concertedly with the proton transfer from H41 to C
β
, in the compound with an activated carbonyl, the sulfur attacks
the carbonyl carbon concomitant with a proton transfer from H41 to
the carbonyl oxygen via the hydroxyl group. An analysis of the free
energy profiles, structures along the reaction path, and interactions
between the inhibitors and the different pockets of the active site
on the protein shows a measurable effect of the warhead on the kinetics
and thermodynamics of the process. These results and QM/MM methods
can be used as a guide to select warheads to design efficient irreversible
and reversible inhibitors of SARS-CoV-2 M
pro
.